Wider eligibility for Paxlovid announced From 1 April the availability of the oral antiviral on the PBS will expand to include over-60s with only one risk factor for severe disease.
GPs ‘essential’ to tackling complacency over influenza New research has found more than a third of Australians underestimate risks of the flu – but nearly half want to discuss preventive options.
Program aims to ‘scale up’ hepatitis C testing GPs are being encouraged to sign up for Beyond the C, which is hoping to move Australia closer to eliminating the virus by 2030.
Long COVID patients display MRI brain changes In a world first study, Australian researchers have found brain structure changes in people with long COVID similar to those with chronic fatigue.
Children’s version of COVID vaccination calculator released While vaccine coverage for 5–11-year-olds remains low, the updated CoRiCal tool could help boost uptake among the cohort.
Three years into the pandemic – what needs to happen next? It’s clear COVID won’t fix itself. Experts Professor Michael Toole and Professor Brendan Crabb outline what we need to focus on next.
Pilot may determine viability of long COVID management models Dr Ken McCroary on the results of tracking post-COVID sequalae in south-west Sydney, and what is needed for long-term viability of a GP-led clinic.
ATAGI gives Moderna bivalent vaccine green light There will soon be two bivalent vaccines available to people aged 12 and over.
RACGP announces cost reduction program Financial headwinds have led the Board and management to enact a three-year plan aimed at making the college more sustainable.
RACGP to advocate for more support at long COVID inquiry There has been an ‘ignored urgency’ to provide better post-viral illness care in Australia, college representative Professor Mark Morgan will argue.